Deletion of Gab2 in mice protects against hepatic steatosis and steatohepatitis: a novel therapeutic target for fatty liver disease

Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis

(2014) Wen-Qing Huang et al.   CURRENT CANCER DRUG TARGETS

A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis

(2014) J. Gautheron et al.   EMBO Molecular Medicine

Tyrosine Phosphatase Shp2 Mediates the Estrogen Biological Action in Breast Cancer via Interaction with the Estrogen Extranuclear Receptor

(2014) Jun Li et al.   PLoS One

Alcoholic liver disease: Treatment

(2014) Ki Tae Suk   WORLD JOURNAL OF GASTROENTEROLOGY

NAFLD leads to liver cancer: Do we have sufficient evidence?

(2013) Xiao-Yan Duan et al.   CANCER LETTERS

Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice

(2013) Wei-Hsuan Hsu et al.   FOOD AND CHEMICAL TOXICOLOGY

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes

(2013) Andreas L. Birkenfeld et al.   HEPATOLOGY

IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro

(2013) Shoichi Kaneshiro et al.   JOURNAL OF BONE AND MINERAL METABOLISM

NAFLD in Asia—as common and important as in the West

(2013) Geoffrey C. Farrell et al.   Nature Reviews Gastroenterology & Hepatology

GAB2 polymorphism rs2373115 confers susceptibility to sporadic Alzheimer's disease

(2013) Chunhui Jin et al.   NEUROSCIENCE LETTERS

SREBP: a novel therapeutic target

(2012) X. Xiao et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Hepatic Src Homology Phosphatase 2 Regulates Energy Balance in Mice

(2012) Naoto Nagata et al.   ENDOCRINOLOGY

Shp2 Controls Female Body Weight and Energy Balance by Integrating Leptin and Estrogen Signals

(2012) Z. He et al.   MOLECULAR AND CELLULAR BIOLOGY

GAB2--a Scaffolding Protein in Cancer

(2012) S. J. Adams et al.   MOLECULAR CANCER RESEARCH

PKA and GAB2 play central roles in the FSH signaling pathway to PI3K and AKT in ovarian granulosa cells

(2012) M. E. Hunzicker-Dunn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PI3K/Akt pathway activation was involved in acute ethanol-induced fatty liver in mice

(2012) Tao Zeng et al.   TOXICOLOGY

Common variant in GAB2 is associated with late-onset Alzheimer's disease in Han Chinese

(2010) Xiao-Ling Zhong et al.   CLINICA CHIMICA ACTA

Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress

(2010) Shomit Sengupta et al.   MOLECULAR CELL

The Akt–SREBP nexus: cell signaling meets lipid metabolism

(2010) James R. Krycer et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Inhibition of JNK along with activation of ERK1/2 MAPK pathways improve steatohepatitis among the rats

(2009) Safiyeh Aghazadeh et al.   CLINICAL NUTRITION

Molecular mechanisms involved in NAFLD progression

(2009) Mariano Malaguarnera et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Molecular Mechanisms of Alcoholic Fatty Liver

(2008) Vishnudutt Purohit et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

(2008) Raj Vuppalanchi et al.   HEPATOLOGY

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

(2008) Herbert Tilg et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM